we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
Respiratory diseases often show similar symptoms, but are triggered by a variety of pathogens, such as viruses, bacteria and fungi. Rapid, comprehensive and reliable diagnostics as a basis for [...]
Human parainfluenza viruses (HPIV) can cause both upper respiratory infections and lower respiratory infections.
As temperatures grow colder, the risk of catching the flu virus rises as well. This year, Australia is experiencing the worst flu epidemic in 15 years. Are Europe and North America also facing [...]
RIDA®GENE Helicobacter pylori is a sensitive and specific real-time PCR assay. It simultaneously detects and differentiates Helicobacter pylori and its resistance to clarithromycin in human [...]
The RIDA®GENE real-time PCR assays for the detection of Influenza (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV) detect the currently circulating drift variant of influenza A (H3N2).
Clostridium difficile is one of the most frequent pathogens in nosocomial infections – but in spite of this many people have never heard of it. Since November is officially “Clostridium [...]
R-Biopharm (Darmstadt) has brought to the market the fastest assay currently available for the specific detection of enterohemorrhagic Escherichia coli (EHEC). With the new RIDA®GENE EHEC/EPEC [...]